A Phase I Dose-Escalation Study to a Predefined Dose of a Transforming Growth Factor-Β1 Monoclonal Antibody (tβm1) in Patients with Metastatic Cancer.
INTERNATIONAL JOURNAL OF ONCOLOGY（2014）
关键词
metastatic cancer,monoclonal antibody inhibitor T beta M1,pharmacodynamic and pharmacokinetic parameters,safety,transforming growth factor-beta 1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要